U.S. pharmacy organizations are advocating for the use of the 2021 race-neutral CKD-EPI equation for “medication-related decisions,” according to a consensus statement. In conjunction with the National Kidney Foundation, pharmacy organizations wrote that the race-neutral CKD-EPI, as opposed to the Cockcroft-Gault estimated creatinine clearance equation, should be the “preferred creatinine-only